Literature DB >> 35673340

Acute ST-Segment Elevation Myocardial Infarction Happened Within 2 Hours after First Dose of COVID-19 Vaccine.

Jen-Hung Huang1,2,3, Jong-Shiuan Yeh1,2,3, Yung-Kuo Lin1,2,3, Ming-Hsiung Hsieh1,2,3.   

Abstract

Entities:  

Year:  2022        PMID： 35673340      PMCID： PMC9121754          DOI： 10.6515/ACS.202205_38(3).20211128A

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN： 1011-6842            Impact factor:   1.800


× No keyword cloud information.
  5 in total

1.  Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.

Authors:  Pedro M Folegatti; Katie J Ewer; Parvinder K Aley; Brian Angus; Stephan Becker; Sandra Belij-Rammerstorfer; Duncan Bellamy; Sagida Bibi; Mustapha Bittaye; Elizabeth A Clutterbuck; Christina Dold; Saul N Faust; Adam Finn; Amy L Flaxman; Bassam Hallis; Paul Heath; Daniel Jenkin; Rajeka Lazarus; Rebecca Makinson; Angela M Minassian; Katrina M Pollock; Maheshi Ramasamy; Hannah Robinson; Matthew Snape; Richard Tarrant; Merryn Voysey; Catherine Green; Alexander D Douglas; Adrian V S Hill; Teresa Lambe; Sarah C Gilbert; Andrew J Pollard
Journal:  Lancet       Date:  2020-07-20       Impact factor: 79.321

Review 2.  Management of acute coronary syndrome in patients with suspected or confirmed coronavirus disease 2019: Consensus from Taiwan Society of Cardiology.

Authors:  Yi-Heng Li; Mei-Tzu Wang; Wei-Chun Huang; Juey-Jen Hwang
Journal:  J Formos Med Assoc       Date:  2020-07-13       Impact factor: 3.282

3.  Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.

Authors:  Andreas Greinacher; Thomas Thiele; Theodore E Warkentin; Karin Weisser; Paul A Kyrle; Sabine Eichinger
Journal:  N Engl J Med       Date:  2021-04-09       Impact factor: 91.245

4.  Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.

Authors:  Renato D Lopes; Pedro Gabriel Melo de Barros E Silva; Remo H M Furtado; Ariane Vieira Scarlatelli Macedo; Bruna Bronhara; Lucas Petri Damiani; Lilian Mazza Barbosa; Júlia de Aveiro Morata; Eduardo Ramacciotti; Priscilla de Aquino Martins; Aryadne Lyrio de Oliveira; Vinicius Santana Nunes; Luiz Eduardo Fonteles Ritt; Ana Thereza Rocha; Lucas Tramujas; Sueli V Santos; Dario Rafael Abregu Diaz; Lorena Souza Viana; Lívia Maria Garcia Melro; Mariana Silveira de Alcântara Chaud; Estêvão Lanna Figueiredo; Fernando Carvalho Neuenschwander; Marianna Deway Andrade Dracoulakis; Rodolfo Godinho Souza Dourado Lima; Vicente Cés de Souza Dantas; Anne Cristine Silva Fernandes; Otávio Celso Eluf Gebara; Mauro Esteves Hernandes; Diego Aparecido Rios Queiroz; Viviane C Veiga; Manoel Fernandes Canesin; Leonardo Meira de Faria; Gilson Soares Feitosa-Filho; Marcelo Basso Gazzana; Idelzuíta Leandro Liporace; Aline de Oliveira Twardowsky; Lilia Nigro Maia; Flávia Ribeiro Machado; Alexandre de Matos Soeiro; Germano Emílio Conceição-Souza; Luciana Armaganijan; Patrícia O Guimarães; Regis G Rosa; Luciano C P Azevedo; John H Alexander; Alvaro Avezum; Alexandre B Cavalcanti; Otavio Berwanger
Journal:  Lancet       Date:  2021-06-04       Impact factor: 79.321

Review 5.  Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations.

Authors:  Nicholas G Kounis; Ioanna Koniari; Cesare de Gregorio; Dimitris Velissaris; Konstantinos Petalas; Aikaterini Brinia; Stelios F Assimakopoulos; Christos Gogos; Sophia N Kouni; George N Kounis; GianFranco Calogiuri; Ming-Yow Hung
Journal:  Vaccines (Basel)       Date:  2021-03-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.